A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4200
Last updated 2017-02-09
Summary
To study the epidemiological trends and characteristics for advanced breast cancer patients, to analyze these trends and report the results
Conditions
Interventions
- DRUG
-
standard therapy
standard therapy for advanced/metastatic breast cancer
Sponsors & Collaborators
-
Chinese Academy of Medical Sciences
lead OTHER
Principal Investigators
-
Binghe Xu · Chinese Academy of Medical Sciences
-
Youlin Qiao · Chinese Academy of Medical Sciences
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-04-30
- Completion
- 2017-12-31
Countries
- China
Study Locations
More Related Trials
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Detection and Analysis of MBC With Heterogeneous ER Expression
NCT05392985 ·Status: COMPLETED
-
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT05079074 ·Status: COMPLETED
-
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Characteristics and Treatment Trends of Young Breast Cancer in China
NCT05068115 ·Status: UNKNOWN
-
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
NCT04265937 ·Status: RECRUITING
-
Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT03260192 ·Status: RECRUITING
-
Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
NCT05427617 ·Status: COMPLETED
-
Familial Breast Cancer in China
NCT06833216 ·Status: NOT_YET_RECRUITING
-
Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients
NCT05901025 ·Status: NOT_YET_RECRUITING
-
Clinical Application of ctDNA in Early Screening of Breast Cancer
NCT03973034 ·Status: UNKNOWN
-
Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China
NCT03792529 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
The Treatment Situation of Chinese County Population With Breast Cancer
NCT05544123 ·Status: UNKNOWN
-
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
NCT03881384 ·Status: UNKNOWN
-
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295 ·Status: RECRUITING
-
A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer
NCT04970264 ·Status: UNKNOWN
-
Breast Tissue Study of Breast Diseases Among Women in Hong Kong
NCT01885039 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)
NCT04156841 ·Status: UNKNOWN
-
Real-world Study of UTD1 in Chinese Advanced Breast Cancer
NCT05386511 ·Status: COMPLETED
-
The Value of Geriatric Assessments in Older Patients With Breast Cancer
NCT03640117 ·Status: UNKNOWN
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
NCT05441098 ·Status: UNKNOWN